TrialBMC cancer2022

GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases.

Fernando Pereira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.